Live News Categoriesequity

Entera Bio Ltd. (5DT.F) News

Follow Entera Bio Ltd. (5DT.F) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 5DT.F Asset equity Sector Markets 90 days 1 Last 2.62 Updated Oct 13, 2026, 11:10 AM UTC Open live news feed

L Entera Bio unveils Phase 3 design for EB613 oral PTH(1 — 34) osteoporosis tablet trial Entera Bio highlighted Phase 2 analyses of EB613, an oral osteoporosis drug candidate, at the ASBMR 2026 annual meeting. Results were already presented at the meeting, pointing to stronger bone-building effects in higher NEWS | Oct 13, 2026, 11:10 AM UTC